Results 91 to 100 of about 9,484 (203)

Fármacos de uso oftálmico, situación actual y nuevos fármacos en desarrollo [PDF]

, 2018
En la actualidad la prescripción de medicamentos para uso oftálmico es de gran importancia, debido alas características únicas del medio ocular.
Serrano Giménez, Pablo
core  

Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials

Clinical Ophthalmology, 2014
Jonathan S Myers,1 Steven Vold,2 Fiaz Zaman,3 Julia M Williams,4 David A Hollander41Wills Eye Hospital, Philadelphia, PA, USA; 2Vold Vision, PLLC, Bentonville, AR, USA; 3Houston Eye Associates, Houston, TX, USA; 4Allergan, Inc., Irvine, CA, USABackground:
Myers JS, Vold S, Zaman F, Williams JM, Hollander DA   +4 more
doaj  

The Efficacy of Latanoprost in the Treatment of Alopecia Areata of Eyelashes and Eyebrows

مجله دانشکده پزشکی اصفهان, 2012
Background: Latanoprost is an analogue of prostaglandin F2a which is used to treat glaucoma. Increases in eyelash number, thickness, and pigmentation have been reported as latanoprost side effects.
Gita Faghihi, Fatemeh Andalib, Ali Asilian   +2 more
doaj  

Short-Term Efficacy and Safety of Switching from a Latanoprost/Timolol Fixed Combination to a Latanoprost/Carteolol Fixed Combination

Clinical Ophthalmology, 2020
Kenji Inoue,1 Hua Piao,1 Mayumi Iwasa,1 Kyoko Ishida,2 Goji Tomita2 1Inouye Eye Hospital, Tokyo, Japan; 2Department of Ophthalmology, Toho University Ohashi Medical Center, Tokyo, JapanCorrespondence: Kenji InoueInouye Eye Hospital, Chiyoda-ku, Tokyo ...
Inoue K, Piao H, Iwasa M, Ishida K, Tomita G   +4 more
doaj  

Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye

International Journal of Nanomedicine, 2012
Jayaganesh V Natarajan1*, Marcus Ang2*, Anastasia Darwitan1, Sujay Chattopadhyay3, Tina T Wong2, Subbu S Venkatraman1 1Materials Science and Engineering, Nanyang Technological University, Singapore; 2Singapore Eye Research Institute, Singapore; 3Polymer ...
Natarajan JV, Ang M, Darwitan A, Chattopadhyay S, Wong TT, Venkatraman SS   +5 more
doaj  

Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes

Indian Journal of Ophthalmology, 2003
Purpose: To compare the short-term efficacy and safety of topical latanoprost and brimonidine in Indian eyes. Materials and Methods: Twenty-eight patients with ocular hypertension, primary open-angle, pseudoexfoliation or pigmentary glaucoma were ...
Thomas Ravi, Parikh Rajul, Muliyil Jayaprakash, George Ronnie, Paul Padma, Abraham Lekha   +5 more
doaj  

Calidad de los ensayos clínicos sobre el glaucoma crónico [PDF]

, 2016
Introducción: El glaucoma crónico es el glaucoma más frecuente que se encuentra en la población, se caracteriza por una tensión ocular alta ya que se inicia por lo general con el aumento de la presión interna del ojo debido a un fallo de drenaje del ...
Pérez Cáceres, Ana R.
core  

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Clinical Ophthalmology
Tsing Hong Wang,1 Tin Aung,2– 4 Da-Wen Lu,5 Ronnie George,6 Sirisha Senthil,7 Fenghe Lu,8 Noriko Odani-Kawabata,9 Ki Ho Park10 1Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan; 2Singapore Eye Research Institute, Singapore
Wang TH, Aung T, Lu DW, George R, Senthil S, Lu F, Odani-Kawabata N, Park KH   +7 more
doaj  

Mirtogenol® potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects

Clinical Ophthalmology, 2010
Robert D Steigerwalt Jr1, Gianni Belcaro1, Paolo Morazzoni2, Ezio Bombardelli2, Carolina Burki3, Frank Schönlau4 1Department of Biomedical Sciences, University of Chieti-Pescara, San Valentino, Italy; 2Indena S.p.A. Scientific Department, Milan,
Robert D Steigerwalt Jr, Gianni Belcaro, Paolo Morazzoni, et al   +3 more
doaj  

Improved Efficacy of Topical Latanoprost 0.005% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism

Clinical Ophthalmology, 2020
Nathan Radcliffe,1 John Berdahl,2 Mitchel Ibach,2 Justin Schweitzer,2 Jason Levine,3 Sean McCafferty3 1New York Eye Surgery Center, New York, NY, USA; 2Vance Thompson Vision, Sioux Falls, SD, USA; 3Arizona Eye Consultants, Tucson, AZ, USACorrespondence ...
Radcliffe N, Berdahl J, Ibach M, Schweitzer J, Levine J, McCafferty S   +5 more
doaj